Summary
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, allowing some to reintroduce allergens post-omalizumab.
Source: Medscape
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
